Player is loading...

Embed

Embed code

Transcriptions

Note: this content has been automatically generated.
00:00:00
I believe the floor more expert
00:00:02
question but Can you give us briefly to
00:00:05
be it become three of those controlled
00:00:08
and procedures that it and how you CD
00:00:11
usable we will see perhaps you can
00:00:14
watch to what the you would like to see
00:00:19
regulation Yeah it you know the end
00:00:24
quote controlling these studies is
00:00:26
certainly one that is a serious one and
00:00:30
going through a difficult control in
00:00:33
India is far more difficult then going
00:00:37
through it in the US and the US will
00:00:40
not give permission into India gives
00:00:42
permission it took us a year and a half
00:00:44
to get the permission to do it. You
00:00:47
know the yeah I I I think what happens
00:00:52
is there are certainly studies that
00:00:55
will show it is giving wiring does not
00:00:59
have and effect and so it's not
00:01:03
absolutely clear that how these studies
00:01:07
work and if you could see in the high
00:01:08
income children there was not and if
00:01:12
that I I think part of my own sort of
00:01:16
way of dealing with it is dealing very
00:01:19
much we have our indian callings they
00:01:21
are true partners in this process. So
00:01:26
it's not parachuting in it at all. Um
00:01:30
and we go through the you know the
00:01:32
ethical standards just as we do with
00:01:34
you know with with and stuff Uh on the
00:01:39
little bits of problems that you say
00:01:41
the early show but it's not on the
00:01:45
radar screen what I was in medical to
00:01:50
which was like century ago this that's
00:01:53
the yeah the formal modelling exactly
00:01:57
monkey later probably or finished sure
00:02:01
absolutely essentially despite its
00:02:03
control for the person and not
00:02:06
devastating consequences. That's but
00:02:10
you're right at absolutely bright those
00:02:12
studies are really landmark studies
00:02:15
that what in in terms of investment in
00:02:18
early child development the investment
00:02:21
has really not been there it's not
00:02:23
there in in the the US and it's not
00:02:27
there there's been very little public
00:02:33
policy reaction very very little
00:02:35
investment so that's what's coming but
00:02:38
you're absolutely right the evidence
00:02:39
it's been there for a long time yes. ah
00:02:52
for just oh oh is that that's a select
00:03:08
I'd I comment on since use oh oh I
00:03:16
question were a it's you see I oh well
00:03:25
that's I you know use is what I yeah
00:03:40
what what what what we would be helpful
00:03:44
because that is this is a small. So
00:03:57
original records that this I I I just
00:04:01
for for Thank you. I it's it it it's a
00:04:08
wonderful comment and I absolutely I
00:04:13
agree you know there is that there was
00:04:15
this a statement it's spearheaded by
00:04:19
the gabby in the it global health last
00:04:24
year that I was part of and others who
00:04:27
work hard out there were interested in
00:04:29
child development we're certainly part
00:04:31
of what has happened is that and the
00:04:36
the the head of the un was talked about
00:04:39
a child development along with the
00:04:42
heads of WHO when units that and where
00:04:45
the combination is is putting what the
00:04:49
health sector dies including vaccines
00:04:52
having child development be part of
00:04:54
that as well. And it's so your comment
00:04:57
is really right on that you know when
00:05:02
we talk about the implementation in
00:05:04
lower middle income countries often
00:05:07
things are very sexual real. So there
00:05:09
is a a health sector and the nutrition
00:05:12
sector is certainly increased but the
00:05:15
child development sectors sort of no
00:05:17
where is it part of education well not
00:05:20
really because the educators tend to
00:05:22
begin at prime every school and they're
00:05:25
indicators are all about primary
00:05:28
school. So early child development
00:05:31
suffers by not having an indicator the
00:05:35
the closest indicator is standing and
00:05:38
child development people are not
00:05:40
satisfied with starting but so your
00:05:43
comment is really right on and there's
00:05:45
an yeah sorry I Agree that what happens
00:05:54
is child development is more than a
00:05:56
vaccination or more than a single shot.
00:05:58
So you how you get and that there's a
00:06:02
new landed series that is coming in two
00:06:04
thousand sixteen that is very much how
00:06:08
to port child development and hell
00:06:11
together right the okay And so the from
00:06:18
basically foundation. Thank you very
00:06:20
much for this broader you the projects
00:06:24
we responded we support are made short
00:06:28
yelp then are exactly the like the one
00:06:32
you mentioned as a we I would not of
00:06:37
course challenge the fact that starting
00:06:41
input is a big health risk until that's
00:06:47
a with timing looking at the WE to
00:06:51
growth occurs definition if you go back
00:06:56
to the number of countries taken you
00:07:00
should be you know to to establish the
00:07:03
scrolls curves. I think the buttons you
00:07:06
can countries what what was more and so
00:07:09
I always had problems accepting these
00:07:14
growth curves for a three population
00:07:18
around the directory in a period wear
00:07:21
malnutrition and are major problems
00:07:26
both you'll you'll be all right if you
00:07:29
got to to close so right now there is
00:07:34
that we will between working since we
00:07:38
don't power a hard point which
00:07:41
challenges LEWHO both the international
00:07:48
goals could and I think it's very
00:07:51
important that we can rely on that it's
00:07:54
a few but you can have faith. no I I
00:07:58
think this certainly agree with your
00:08:00
comment they were a you don't step
00:08:02
forward from relying on either local
00:08:06
references for the reference is used in
00:08:08
the US but it's you know it is it is
00:08:12
true it is striking in those these very
00:08:16
barry countries that I think you saw
00:08:20
similar growth but you know as with
00:08:23
many things in science it's a step
00:08:25
forward not necessarily the final step
00:08:27
I oh well there was a little yellow but
00:08:33
I wish I had a problem in and regard is
00:08:35
that once a question ethics you failed
00:08:37
to mention some stuff to Moody Allende
00:08:39
was actually different yes that's true
00:08:42
we have to we never know we're doing
00:08:44
more it's true I can point about
00:08:47
standing everybody who knew anything
00:08:49
raised a hand and it's starting had
00:08:51
worked outcomes. But I'd like to
00:08:53
emphasise at least in my opinion is not
00:08:55
that they were small. It's about sex
00:08:57
that it would not have small that we
00:08:59
should make that what you were making
00:09:01
them small stresses and the apples I so
00:09:05
that the they them small which gives
00:09:07
them the address cool okay. So I case
00:09:12
it what they do small not be small just
00:09:15
yet what I would say is that there's
00:09:17
also an outcome of being small. And
00:09:20
what happens what are the consequences
00:09:22
of the being small the expectations on
00:09:26
a child to a small or reduced. So the
00:09:30
expectations from a teacher or from a
00:09:33
parent or from here may be reduced to
00:09:36
the child to a small the child
00:09:38
perceives of themselves as being
00:09:41
potentially less competent less able to
00:09:44
do things so there's not only one
00:09:46
pathway that means that few minutes to
00:09:49
and finally the EDI right you brought
00:09:51
up the actual because it is a
00:09:53
tremendous inflammatory and infectious
00:09:56
try. This link back to the previous
00:09:58
paper or to that period life. And the
00:10:02
consumption of group. We should get a
00:10:05
laboratory cells also I want to go to
00:10:08
bed did the bottom so rubber right in
00:10:11
and they implement on there was size
00:10:15
building somebody should do you think
00:10:17
Very short term general but that's
00:10:21
that's the that's the two so we're
00:10:22
concerned about that some kids don't
00:10:25
get there by means because in the
00:10:27
control room what we're looking at is
00:10:29
into individual variability. So put
00:10:33
everybody in the in the intervention
00:10:35
group in the US how it will look in a
00:10:39
relational data from baseline house
00:10:41
technology. But then you can see data
00:10:44
and you say I used are and how they
00:10:47
stuff. So you can you both at the same
00:10:50
hi without losing the inside. with it
00:10:54
certainly there are other I you know
00:10:55
other designs to to doing that and it
00:10:58
is a it is the question one of the
00:10:59
things that we do also that I didn't
00:11:02
mention is that all of the children
00:11:05
receive the you know will receive the
00:11:10
fortification for than for the next
00:11:13
year again the fortification is is very
00:11:16
low income so it's just the
00:11:18
distribution cost so yes that's good oh

Share this talk: 


Conference Program

Introduction to the 12th Nestlé International Nutrition Symposium
Thomas Beck, NRC Director
22 Oct. 2015 · 8:57 a.m.
418 views
Introduction to Session I - Cognitive & Brain Development
Susan Gasser, Friedrich Miescher Institute, Basel, Switzerland
22 Oct. 2015 · 9:04 a.m.
The development of a healthy brain
Michael Gazzaniga, University of California, Santa Barbara, USA
22 Oct. 2015 · 9:16 a.m.
221 views
Q&A - The development of a healthy brain
Michael Gazzaniga, University of California, Santa Barbara, USA
22 Oct. 2015 · 9:56 a.m.
Early influences on brain development and epigenetics
Stephen G. Matthews, University of Toronto, Canada
22 Oct. 2015 · 10:49 a.m.
Q&A - Early influences on brain development and epigenetics
Stephen G. Matthews, University of Toronto, Canada
22 Oct. 2015 · 11:29 a.m.
Building the physiology of thought
Rebecca Saxe, Massachusetts Institute of Technology, Cambridge, USA
22 Oct. 2015 · 11:38 a.m.
154 views
Q&A - Building the physiology of thought
Rebecca Saxe, Massachusetts Institute of Technology, Cambridge, USA
22 Oct. 2015 · 12:10 p.m.
Introduction to Session II - Cognitive Decline
Kathinka Evers
22 Oct. 2015 · 2:02 p.m.
Brain health & brain diseases - future perspectives
Richard Frackowiak, CHUV University Hospital, Lausanne, Switzerland
22 Oct. 2015 · 2:11 p.m.
Alzheimer's disease: genome-wide clues for novel therapies
Rudolph E. Tanzi, Massachusetts General Hospital, Charlestown, USA
22 Oct. 2015 · 3:15 p.m.
Q&A - Alzheimer's disease: genome-wide clues for novel therapies
Rudolph E. Tanzi, Massachusetts General Hospital, Charlestown, USA
22 Oct. 2015 · 3:59 p.m.
Immunometabolic regulators of age-related inflammation
Vishwa D. Dixit, Yale School of Medicine, New Haven, USA
22 Oct. 2015 · 4:21 p.m.
Q&A - Immunometabolic regulators of age-related inflammation
Vishwa D. Dixit, Yale School of Medicine, New Haven, USA
22 Oct. 2015 · 4:59 p.m.
Introduction to Session III - Nutrition & Cognitive Development
Pierre Magistretti, KAUST, Thuwal, Saudi Arabia and EPFL, Lausanne, Switzerland
23 Oct. 2015 · 9 a.m.
Energy metabolism in long-term memory formation and enhancement
Cristina M. Alberini, The Center for Neural Science, New York University, USA
23 Oct. 2015 · 9:16 a.m.
129 views
Q&A - Energy metabolism in long-term memory formation and enhancement
Cristina M. Alberini, The Center for Neural Science, New York University, USA
23 Oct. 2015 · 9:53 a.m.
Building the costly human brain: implications for the evolution of slow childhood growth and the origins of diabetes
Christopher Kuzawa, Northwestern University, Evanston, USA
23 Oct. 2015 · 10:29 a.m.
Q&A - Building the costly human brain: implications for the evolution of slow childhood growth and the origins of diabetes
Christopher Kuzawa, Northwestern University, Evanston, USA
23 Oct. 2015 · 10:57 a.m.
Nutrition, growth and the developing brain
Prof. Maureen Black, University of Maryland, School of Medicine, Baltimore, USA
23 Oct. 2015 · 11:09 a.m.
Q&A - Nutrition, growth and the developing brain
Prof. Maureen Black, University of Maryland, School of Medicine, Baltimore, USA
23 Oct. 2015 · 11:49 a.m.
Introduction to Session IV - Decline & Nutritional Intervention
Tamas Bartfai, The Scripps Research Institute, La Jolla, USA
23 Oct. 2015 · 12:48 p.m.
On multi-domain approaches for prevention trials
Miia Kivipelto, Karolinska Institutet, Stockholm, Sweden
23 Oct. 2015 · 1:04 p.m.
Q&A - On multi-domain approaches for prevention trials
Miia Kivipelto, MD, PhD, Karolinska Institutet
23 Oct. 2015 · 1:39 p.m.
Methodological challenges in Alzheimer clinical development
Lon S. Schneider, Keck School of Medicine of USC, Los Angeles, USA
23 Oct. 2015 · 1:49 p.m.
Q&A - Methodological challenges in Alzheimer clinical development
Lon S. Schneider, Keck School of Medicine of USC, Los Angeles, USA
23 Oct. 2015 · 2:32 p.m.
We are what we remember: memory and age related memory disorders
Eric R. Kandel, Columbia University, New York, USA
23 Oct. 2015 · 3:03 p.m.
138 views
Concluding Remarks
Stefan Catsicas, Chief Technology Officer, Nestlé SA
23 Oct. 2015 · 3:50 p.m.

Recommended talks

Q&A : Fecal transplant to mine for novel probiotics
Max Nieuwdorp, Amsterdam Medical Center, The Netherlands
24 Oct. 2014 · 11:25 a.m.